maleimide has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, ON; Jung, S; Lee, EK; Lee, SH; Thi Nguyen, NT | 1 |
| Chen, X; Gao, S; Jacobson, O; Kiesewetter, DO; Lang, L; Liu, Y; Ma, Q; Ma, Y; Wang, G; Zhang, H; Zhu, L | 1 |
2 other study(ies) available for maleimide and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Mono-PEGylates of exenatide in branched and dimeric structures can improve in vivo stability and hypoglycemic bioactivity.
Topics: Amino Acid Sequence; Animals; Blood Glucose; CHO Cells; Cricetulus; Cyclic AMP; Diabetes Mellitus, Type 2; Disease Models, Animal; Exenatide; Glucagon-Like Peptide-1 Receptor; Half-Life; Hypoglycemic Agents; Maleimides; Mice; Mice, Nude; Mice, Obese; Molecular Weight; Polyethylene Glycols | 2019 |
Stable Evans Blue Derived Exendin-4 Peptide for Type 2 Diabetes Treatment.
Topics: Animals; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Stability; Evans Blue; Exenatide; Humans; Hypoglycemic Agents; Maleimides; Mice, Inbred C57BL; Naphthalenesulfonates; Peptides; Serum Albumin; Venoms | 2016 |